Indaptus Therapeutics, Inc. (INDP)
2.26
-0.33
(-12.74%)
USD |
NASDAQ |
Oct 07, 16:00
2.36
+0.10
(+4.42%)
After-Hours: 07:56
Indaptus Therapeutics Shareholders Equity (Quarterly) : 11.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.37M |
| March 31, 2026 | 1.248M |
| December 31, 2025 | 3.152M |
| September 30, 2025 | 4.606M |
| June 30, 2025 | -1.673M |
| March 31, 2025 | 2.800M |
| December 31, 2024 | 3.945M |
| September 30, 2024 | 6.003M |
| June 30, 2024 | 6.166M |
| March 31, 2024 | 9.361M |
| December 31, 2023 | 12.08M |
| September 30, 2023 | 15.33M |
| June 30, 2023 | 18.63M |
| March 31, 2023 | 21.19M |
| December 31, 2022 | 24.63M |
| September 30, 2022 | 27.57M |
| June 30, 2022 | 30.41M |
| March 31, 2022 | 33.36M |
| December 31, 2021 | 35.90M |
| September 30, 2021 | 38.08M |
| June 30, 2021 | 13.94M |
| March 31, 2021 | 11.34M |
| December 31, 2020 | -0.2377M |
| September 30, 2020 | 18.08M |
| June 30, 2020 | 16.18M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.22M |
| December 31, 2019 | 11.54M |
| September 30, 2019 | 17.49M |
| June 30, 2019 | 35.11M |
| March 31, 2019 | 44.09M |
| December 31, 2018 | 53.54M |
| September 30, 2018 | 65.34M |
| June 30, 2018 | 73.67M |
| March 31, 2018 | 48.80M |
| December 31, 2017 | 58.80M |
| September 30, 2017 | 68.72M |
| June 30, 2017 | 21.58M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 35.63M |
| September 30, 2015 | 38.23M |
| June 30, 2015 | 9.006M |
| March 31, 2015 | 7.473M |
| December 31, 2014 | 9.475M |
| September 30, 2014 | 6.047M |
| June 30, 2014 | 7.011M |
| March 31, 2014 | 8.112M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 246.22M |
| Cypherpunk Technologies, Inc. | 139.32M |
| Ocugen, Inc. | -16.56M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.99M |
| Total Liabilities (Quarterly) | 0.6154M |
| Current Ratio | 19.48 |
| Net Debt Paydown Yield | 0.00% |